Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | L3MBTL1 | Q9Y468 | 3/20 | 0.51 |
| ▸ | POLB | P06746 | 1/20 | 0.51 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.43 |
| ▸ | MEN1 | O00255 | 2/20 | 0.43 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.43 |
| ▸ | PPARG | P37231 | 7/20 | 0.41 |
| ▸ | PPARA | Q07869 | 7/20 | 0.41 |
| ▸ | PPARD | Q03181 | 5/20 | 0.41 |
| ▸ | PTGDR2 | Q9Y5Y4 | 2/20 | 0.39 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.39 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.39 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.39 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.39 |
| ▸ | HTT | P42858 | 1/20 | 0.38 |
| ▸ | MAPT | P10636 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4328778 | 0.90 | GAA (0.47) | L3MBTL1KMT2AMEN1SMN1; SMN2PPARG | |
| SCHEMBL4341908 | 0.86 | PPARG (0.47) | L3MBTL1KMT2AMEN1SMN1; SMN2PPARG | |
| SCHEMBL4335537 | 0.85 | KMT2A (0.58) | L3MBTL1POLBKMT2AMEN1SMN1; SMN2 | |
| SCHEMBL4329764 | 0.84 | ACACB (0.42) | L3MBTL1SMN1; SMN2PPARGPPARAPPARD | |
| SCHEMBL4341998 | 0.83 | CYP1A2 (0.43) | L3MBTL1POLBKMT2AMEN1SMN1; SMN2 | |
| SCHEMBL6654698 | 0.83 | PTGDR2 (0.51) | KMT2AMEN1SMN1; SMN2PPARGPPARA | |
| SCHEMBL4333132 | 0.82 | GAA (0.44) | L3MBTL1POLBKMT2AMEN1SMN1; SMN2 | |
| SCHEMBL4342690 | 0.81 | PPARG (0.48) | POLBKMT2AMEN1SMN1; SMN2PPARG | |
| SCHEMBL4327189 | 0.81 | PPARG (0.48) | POLBKMT2AMEN1SMN1; SMN2PPARG | |
| SCHEMBL4335678 | 0.81 | PPARA (0.44) | L3MBTL1KMT2AMEN1SMN1; SMN2PPARG |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20040102634-A1 | Carboxylic acid derivative and salt thereof | EISAI R&D MANAGEMENT CO., LTD. (JP) | 2004-05-27 | — | — | US | disclosed |
| EP-1380562-A1 | CARBOXYLIC ACID DERIVATIVE AND SALT THEREOF | Eisai Co., Ltd. (JP) | 2004-01-14 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040102634-A1 | Carboxylic acid derivative and salt thereof | GPR119, IRS1, SLC5A1 | L3MBTL1 3856/4885POLB 3622/4885KMT2A 2774/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.